State Street’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $475M | Sell |
|
|||||
|
2025
Q2 | $486M | Buy |
|
|||||
|
2025
Q1 | $598M | Sell |
|
|||||
|
2024
Q4 | $599M | Buy |
|
|||||
|
2024
Q3 | $620M | Sell |
|
|||||
|
2024
Q2 | $793M | Buy |
|
|||||
|
2024
Q1 | $602M | Buy |
|
|||||
|
2023
Q4 | $649M | Buy |
|
|||||
|
2023
Q3 | $571M | Buy |
|
|||||
|
2023
Q2 | $516M | Sell |
|
|||||
|
2023
Q1 | $590M | Buy |
|
|||||
|
2022
Q4 | $558M | Buy |
|
|||||
|
2022
Q3 | $447M | Sell |
|
|||||
|
2022
Q2 | $447M | Buy |
|
|||||
|
2022
Q1 | $415M | Buy |
|
|||||
|
2021
Q4 | $470M | Buy |
|
|||||
|
2021
Q3 | $389M | Buy |
|
|||||
|
2021
Q2 | $409M | Buy |
|
|||||
|
2021
Q1 | $353M | Sell |
|
|||||
|
2020
Q4 | $435M | Buy |
|
|||||
|
2020
Q3 | $372M | Sell |
|
|||||
|
2020
Q2 | $635M | Sell |
|
|||||
|
2020
Q1 | $468M | Buy |
|
|||||
|
2019
Q4 | $415M | Buy |
|
|||||
|
2019
Q3 | $329M | Buy |
|
|||||
|
2019
Q2 | $402M | Buy |
|
|||||
|
2019
Q1 | $412M | Buy |
|
|||||
|
2018
Q4 | $332M | Sell |
|
|||||
|
2018
Q3 | $382M | Buy |
|
|||||
|
2018
Q2 | $358M | Sell |
|
|||||
|
2018
Q1 | $326M | Buy |
|
|||||
|
2017
Q4 | $356M | Sell |
|
|||||
|
2017
Q3 | $374M | Buy |
|
|||||
|
2017
Q2 | $354M | Sell |
|
|||||
|
2017
Q1 | $351M | Buy |
|
|||||
|
2016
Q4 | $310M | Buy |
|
|||||
|
2016
Q3 | $336M | Buy |
|
|||||
|
2016
Q2 | $261M | Buy |
|
|||||
|
2016
Q1 | $271M | Buy |
|
|||||
|
2015
Q4 | $326M | Buy |
|
|||||
|
2015
Q3 | $327M | Buy |
|
|||||
|
2015
Q2 | $388M | Buy |
|
|||||
|
2015
Q1 | $351M | Buy |
|
|||||
|
2014
Q4 | $240M | Sell |
|
|||||
|
2014
Q3 | $286M | Sell |
|
|||||
|
2014
Q2 | $269M | Buy |
|
|||||
|
2014
Q1 | $265M | Buy |
|
|||||
|
2013
Q4 | $224M | Buy |
|
|||||
|
2013
Q3 | $177M | Sell |
|
|||||
|
2013
Q2 | $174M | Buy |
|